CCL4 as a Potential Immune-Metabolic Biomarker in Acute Myocardial Infarction via Machine Learning and Single-Cell Transcriptomics.
Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide, highlighting the need for novel complementary biomarkers. By integrating bulk and single-cell transcriptomic data with machine learning approaches, calmodulin-related genes associated with AMI and explored their immune-metabolic...